Clinical Trial Update: D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder [Phase 2]

View source ↗

Summary

Phase 2 study evaluating D-Cycloserine augmentation of exposure and response prevention for obsessive-compulsive disorder has been withdrawn. Sponsor is the Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: University of Florida | Conditions: Obsessive Compulsive Disorder | Phase 2 | Status: WITHDRAWN